INGN
Inogen Inc
NASDAQ: INGN · HEALTHCARE · MEDICAL DEVICES
$7.11
+1.57% today
Updated 2026-04-30
Market cap
$197.44M
P/E ratio
—
P/S ratio
0.57x
EPS (TTM)
$-0.86
Dividend yield
—
52W range
$5 – $9
Volume
0.3M
Inogen Inc (INGN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.86M | $4.00M | $13.47M | $15.70M | $38.16M | $31.03M | $60.49M | $59.98M | $40.59M | $37.01M | $23.63M | $-37.53M | $-3.23M | $5.91M | $-11.22M |
| Capital expenditures | $8.96M | $12.45M | $18.14M | $16.24M | $12.49M | $8.02M | $10.23M | $12.97M | $6.51M | $17.34M | $23.93M | $21.22M | $26.52M | $17.09M | $10.38M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $144000.00 | $60000.00 | $230000.00 | $1.45M | $3.64M | $7.29M | $9.64M | $12.79M | $9.13M | $8.20M | $10.94M | $12.28M | $7.43M | $7.40M | $8.01M |
| Free cash flow | $-7.10M | $-8.44M | $-4.67M | $-540000.00 | $25.67M | $23.02M | $50.27M | $47.00M | $34.08M | $19.67M | $-302000.00 | $-58.75M | $-29.75M | $-11.18M | $-21.60M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $43.31M | $9.27M | $26.75M | $50.10M | $53.31M | $1.47M | $13.44M | $23.99M | $-48.03M | — | — | — |